Christopher Carl Collins, Director, Ten Percent Owner at Amplia Therapeutics Ltd., holds 37.89M shares in Amplia Therapeutics Ltd. (Ticker: INNMF). Most recently, Christopher Carl Collins Bought $4,000,000 shares of Amplia Therapeutics Ltd. on Sep 12, 2016 for an estimated value of 1.00M.
What is the percentage of profitable transactions made by Christopher Carl Collins?
The percentage of profitable transactions made by Christopher Carl Collins is ―.
What is the average return per transaction made by Christopher Carl Collins?
The average return per transaction made by Christopher Carl Collins is ―.
What stocks does Christopher Carl Collins hold?
Christopher Carl Collins holds: INNMF stocks.
What was Christopher Carl Collins’s latest transaction?
Christopher Carl Collins latest transaction was an Informative Buy of $1.00M.
What was Christopher Carl Collins's most profitable transaction?
Christopher Carl Collins’s most profitable transaction was an Informative Buy of INNMF stock on September 12, 2016. The return on the trade was -93.30%.
What is Christopher Carl Collins's role in Amplia Therapeutics Ltd.?
Christopher Carl Collins's role in Amplia Therapeutics Ltd. is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.